[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Black Swan Analysis limited: Market Research Reports

Black Swan Analysis is a provider of insightful commercialization ideas for the clients engaged in the healthcare sector.

The company delivers one-of-a-kind solutions, reliable epidemiology data, market and product overviews, and business opportunity evaluation for the clients who want to increase their capacity in producing and selling healthcare products.

Black Swan Analysis is an unrestricted resource of avant-garde solutions to the clients who want to upgrade their performance at the healthcare market. Our experience and ability to penetrate to the core of the problem enable us to produce exclusive market research reports that contain a variety of useful information including:

  • Product profile
  • SWOT analysis
  • Growth drivers
  • Market share
  • Supply and demand channels
  • Analysis of Competitors’ products and services
  • New application areas

To ensure precise forecasting, we explore and analyze a vast variety of epidemiological and pathological data and study disease environment. Our clients can access disease epidemiology information and receive the accurate evaluation of the pricing policies of proprietors in the healthcare and pharmaceutical business.

We do not let our customers leave our company with half-baked information and weak decisions. Clients with unmet expectations are not about us. They appreciate Black Swan Analysis for adaptable solutions, proficiency, cost-effectiveness, and unique methodologies.

We help our pharmaceutical and healthcare partners recharge their capacities and increase their competitive rates. Our service algorithm is to work in close cooperation with the customer. Consistent inclusive communication helps us approach every commercial challenge expertly and invent unique business solutions.

Publications found: 186
Sort by:

Epiomic Epidemiology Series: Osteoarthritis Forecast in 9 Major Markets 2016-2026

US$ 6,150.00

... level across the 10-year forecast snapshot. There are a number of ... from the proprietary Epiomic patient segmentation database. To ... registries, clinical trials and epidemiology studies. All of the ... conditions on Osteoarthritis’s prevalent population. Identify sub-populations within Osteoarthritis which require ...

September 2016 64 pages

Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

US$ 4,930.00

... information sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Rheumatoid Arthritis’s prevalent population. Identify sub-populations within Rheumatoid Arthritis which require treatment ...

September 2016 74 pages

Epiomic Epidemiology Series: Lower Back Pain and Sciatica Forecast in 9 Major Markets 2016-2026

US$ 4,250.00

... and information sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources used ... morbid conditions on Lower Back Pain’s prevalent population. Identify sub-populations within Lower Back Pain which ...

September 2016 46 pages

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

US$ 4,930.00

... accurate patient population estimates, the Epiomic database utilises a combination of several ... from patient registries, clinical trials and epidemiology studies. All of the sources used ... conditions on Traumatic Brain Injury's incident population. Identify sub-populations within Traumatic Brain Injury which ...

September 2016 82 pages

Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

US$ 4,930.00

... information sourced from the proprietary Epiomic patient segmentation database. To ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Hodgkin’s Lymphoma incident population. Identify sub-populations within Hodgkin’s Lymphoma which require treatment ...

September 2016 60 pages

Epiomic Epidemiology Series: Haemophagocytic lymphohistiocytosis (HLH) Forecast in 14 Major Markets 2016-2026

US$ 4,250.00

... sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the sources ... conditions on Haemophagocytic lymphohistiocytosis’s incident population. Identify sub-populations within Haemophagocytic lymphohistiocytosis which require ...

September 2016 52 pages

Epiomic Epidemiology Series: Asthma Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

... level across the 10-year forecast snapshot. The main co-morbidities associated with asthma include: ... Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database ... from patient registries, clinical trials and epidemiology studies. All of the sources used ...

August 2016 60 pages

Epiomic Epidemiology Series: Cachexia Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

... across the 10-year forecast snapshot. Key underlying pathologies linked with developing cachexia include: ... information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...

August 2016 46 pages

Epiomic Epidemiology Series: Sarcopenia Forecast in 13 Major Markets 2016-2026

US$ 6,382.00

... country level across the 10-year forecast snapshot. Diseases associated with sarcopenia: Obesity Type 2 ... information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...

August 2016 50 pages

Epiomic Epidemiology Series: Non-Melanoma Skin Cancer Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

... information sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources used ... on the Non-melanoma skin cancer prevalent population. Identify sub-populations within Non-melanoma skin cancer which require ...

August 2016 40 pages

Epiomic Epidemiology Series: Alpha-1 Anti-Trypsin Deficiency Forecast in 9 Major Markets 2016-2026

US$ 6,382.00

... information sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources used ... on the Alpha-1 Anti-Trypsin prevalent population. Identify sub-populations within Alpha-1 Anti-Trypsin which require treatment. ...

August 2016 36 pages

Epiomic Epidemiology Series: HIV Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for HIV include: Impaired ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...

August 2016 42 pages

Epiomic Epidemiology Series: Hip Fractures and Replacements - Forecast for the USA 2016-2026

US$ 3,200.00

... Hip Fractures include: Osteoporosis and osteopenia Female Older age This report is built using data and information sourced from the proprietary Epiomic ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and ...

July 2016 28 pages

Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 14 Major Markets 2016-2026

US$ 6,382.00

... Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database ... from patient registries, clinical trials and epidemiology studies. All of the sources used ... conditions on Dry Eye Syndrome’s prevalent population. Identify sub-populations within Dry Eye Syndrome which ...

July 2016 58 pages

Epiomic Epidemiology Series: Autoimmune Haemolytic Anemia Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

Autoimmune haemolytic anaemia (AIHA) is an immune disorder caused ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

June 2016 48 pages

Epiomic Epidemiology Series: Malignant Melanoma Forecast in 20 Major Markets 2016-2026

US$ 6,382.00

... symptoms and co-morbidities for Malignant Melanoma include: Family history of Malignant Melanoma Atypical nevus syndrome Exposure ... information sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources used ...

May 2016 88 pages

Market Report for PET Imaging in Japan

US$ 9,020.00

... Swan, an introduction on PET imaging is given, as well as information on: The utilization of PET and the development of the PET modality over time in the Japan market Current Japan healthcare system and reimbursement for PET imaging Market evolution and ...

April 2016 72 pages

Market Report for PET Imaging in the USA

US$ 6,400.00

... Swan, an introduction on PET imaging is given, as well as information on: The utilization of PET and the development of the PET modality over time in the USA market Current USA healthcare system and reimbursement for PET imaging Market evolution ...

April 2016 139 pages

Market Report for PET Imaging in Top 5 EU Markets

US$ 16,540.00

... Swan, an introduction on PET imaging is given, as well as information on: The utilization of PET and the development of the PET modality over time in the T5 EU markets Current T5 EU healthcare systems and their reimbursement schemes for PET imaging Market evolution ...

April 2016 157 pages

Epiomic Epidemiology Series: Growth Hormone Deficiency Forecast in 9 Major Markets 2016-2026

US$ 6,382.00

... and is characterized by the inadequate secretion of growth hormone (GH), from the anterior pituitary ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used to ...

April 2016 46 pages

Epiomic Epidemiology Series: Bladder Cancer Forecast in 18 Major Markets 2016-2026

US$ 6,382.00

... Occupation Bladder infections Bladder stones Family history of bladder cancer This report is built using data and information sourced from the proprietary Epiomic patient ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data ...

April 2016 66 pages

Epiomic Epidemiology Series: Traumatic Spinal Cord Injury Forecast in 15 Major Markets 2016-2026

US$ 6,382.00

... . Traumatic spinal cord injury (TSCI) is classified as injury to the spine caused by a traumatic event ... information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...

April 2016 62 pages

Epiomic Epidemiology Series: Dysmenorrhea Forecast in 21 Major Markets 2016-2026

US$ 6,382.00

... of dysmenorrhea Early age at menarche Nulliparity Exercise level / fitness This report is built using data and information sourced from the proprietary Epiomic ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and ...

April 2016 54 pages

Epiomic Epidemiology Series: Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026

US$ 6,382.00

... co-morbidities for Brain & CNS Cancer include: Genetic susceptibility Family history of brain & CNS ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used to ...

April 2016 66 pages

Epiomic Epidemiology Series: Amyotrophic Lateral Sclerosis Forecast in 9 Major Markets 2016-2026

US$ 6,382.00

Amyotrophic lateral sclerosis (ALS), also called Lou Gehrig ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population ... date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

March 2016 42 pages

Epiomic Epidemiology Series: Glaucoma Forecast in 10 Major Markets 2016-2026

US$ 6,382.00

... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Glaucoma include: ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...

March 2016 48 pages

Epiomic Epidemiology Series: Tay-Sachs Disease Forecast in 9 Major Markets 2016-2026

US$ 6,382.00

... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Tay-Sachs disease prevalent population. Identify sub-populations within Tay-Sachs disease which require treatment ...

March 2016 36 pages

Epiomic Epidemiology Series: Primary Immunodeficiency Disease Forecast in 21 Major Markets 2016-2026

US$ 6,382.00

Primary immunodeficiency diseases (PID) are a group of inherited ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

March 2016 76 pages

Chronic Kidney Disease Forecast in 19 Major Markets 2016-2026

US$ 6,382.00

... Series Forecast Report on Chronic Kidney Disease (CKD) in 19 Major Markets Chronic kidney disease (CKD), also known as chronic renal disease, is characterised by progressive loss of kidney function over time. CKD is defined as persisting kidney ...

March 2016 74 pages

Epiomic Epidemiology Series: Age-Related Macular Degeneration Forecast in 7 Major Markets 2016-2026

US$ 6,382.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Essential Thrombocythemia (ET) in 9 Major Markets Essential Thrombocythemia (ET) or Primary ... , Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also ...

March 2016 40 pages

Epiomic Epidemiology Series: Essential Thrombocythemia Forecast in 9 Major Markets 2016-2026

US$ 6,382.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Age-related Macular Degeneration (AMD) Disease in 7 Major ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and ...

March 2016 40 pages

Epiomic Epidemiology Series: Primary Myleofibrosis Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Primary Myelofibrosis (PMF) in 8 Major Markets Primary Myelofibrosis (PMF), also known as myelofibrosis, myeloid metaplasia or chronic idiopathic ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and ...

March 2016 40 pages

Epiomic Epidemiology Series: Addison's Disease Forecast in 10 Major Markets 2016-2026

US$ 6,382.00

... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Addison’s disease’s prevalent population. Identify sub-populations within Addison’s disease which require treatment ...

February 2016 38 pages

Epiomic Epidemiology Series: Behcet's Disease Forecast in 12 Major Markets 2016-2026

US$ 6,382.00

... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Behcet’s disease’s prevalent population. Identify sub-populations within Behcet’s disease which require treatment ...

February 2016 60 pages

Epiomic Epidemiology Series: Benign Prostatic Hypertrophy Forecast in 17 Major Markets 2016-2026

US$ 6,382.00

Benign Prostatic Hypertrophy (BPH) is a noncancerous (benign) enlargement of the prostate gland that ... Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database ... from patient registries, clinical trials and epidemiology studies. All of the sources used ...

February 2016 48 pages

Epiomic Epidemiology Series: Familial Dyslipidaemia Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

... several of the main symptoms and co-morbidities of Familial Dyslipidaemia have been quantified and ... familial) Xanthomas (familial) This report is built using data and information sourced from the proprietary Epiomic ... from patient registries, clinical trials and epidemiology studies. All of the sources used ...

February 2016 40 pages

Epiomic Epidemiology Series: Juvenile Idiopathic Arthritis Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

Juvenile Idiopathic Arthritis (JIA) is an auto-immune disorder defined ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

February 2016 44 pages

Epiomic Epidemiology Series: Prader-Willi Syndrome Forecast in 9 Major Markets 2016-2026

US$ 6,382.00

Prader-Willi syndrome (PWS) is a genetic disease caused by the loss of ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

February 2016 40 pages

Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026

US$ 6,382.00

... Stomach Cancer include: History of stomach polyps or stomach lymphoma Family history of stomach cancer Family history of hereditary non-polyposis Colorectal cancer ... sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the ...

February 2016 66 pages

Epiomic Epidemiology Series: Transient Ischaemic Attack Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

Transient ischaemic attack (TIA), also known as a mini or ... the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises ... date information from patient registries, clinical trials and epidemiology studies. All of the sources used to ...

February 2016 40 pages

Epiomic Epidemiology Series: Restless Leg Syndrome Forecast in 13 Major Markets 2016-2026

US$ 6,382.00

... information sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources used ... conditions on Restless Legs Syndrome’s prevalent population. Identify sub-populations within Restless Legs Syndrome which ...

January 2016 52 pages

Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026

US$ 6,382.00

... Pancreatic Cancer include: • Obesity • Diabetes • Jaundice • Pancreatitis • Gallbladder enlargement This report is built using data and information sourced from the proprietary Epiomic ... to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the ...

January 2016 54 pages

Epiomic Epidemiology Series: Peripheral Arterial Disease Forecast in 20 Major Markets 2016-2026

US$ 6,382.00

Peripheral Arterial disease (PAD) is an occlusion of the peripheral arteries and is widely viewed as a measure of an individual's global systemic atherosclerotic burden. Typically, it is defined as an ankle-brachial pressure index (APBI) ratio of

January 2016 80 pages

Epiomic Epidemiology Series: Symptomatic Vitreomacular Adhesion Forecast in 9 Major Markets 2016-2026

US$ 6,382.00

Symptomatic Vitreomacular adhesion (VMA) is a rare macular condition ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...

January 2016 40 pages

Epiomic Epidemiology Series: Systemic Lupus Erythematosus Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

Systemic Lupus Erythematosus (SLE) is an autoimmune disease, characterised by an autoantibody response to nuclear and cytoplasmic antigens. It is a systemic ... Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic ... , clinical trials and epidemiology studies. All of ...

January 2016 48 pages

Epiomic Epidemiology Series: Ulcerative Colitis Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

... sourced from the proprietary Epiomic patient segmentation database. To generate ... patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Ulcerative Colitis’s prevalent population. • Identify sub-populations within Ulcerative Colitis which require treatment. ...

January 2016 42 pages

Epiomic Epidemiology Series: Crohn's Disease Forecast in 8 Major Markets 2016-2026

US$ 6,382.00

... Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Crohn’s Disease in 8 Major Markets Crohn's disease, also known as regional enteritis, is a type of chronic inflammatory bowel disease. While it may affect ... on the impact from specific co-morbid conditions on Crohn’s disease’s prevalent population. Identify sub-populations within Crohn’s disease which require treatment. Gain an understanding of the ...

January 2016 48 pages

Epiomic Epidemiology Series: Neuropathic Pain Forecast in 15 Major Markets 2016-2026

US$ 6,382.00

... Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Neuropathic Pain in 15 Major Markets Neuropathic pain is generally defined as chronic pain resulting from injury to the nervous system. Neuropathic pain is caused by other ... on the impact from specific co-morbid conditions on Neuropathic Pain’s prevalent population. Identify sub-populations within Neuropathic Pain which require treatment. Gain an understanding of the ...

January 2016 56 pages

Filters

Search

Categories

2
1
5
11
167

Publishers

186

Regions

2
1
1
182

Price

Date

Pages

Offers